enGene Holdings Inc. Common Stock share price logo

enGene Holdings Inc. Common Stock

NASDAQ: ENGN

Small Cap

$1.55

+0.11

(+7.64%)

Live

as on

enGene Holdings Inc. Common Stock Stock Performance

as on May 14, 2026 at 4:10 am IST

  • Day's Low

    Day's High

    $1.44
    $1.60
    downward going graph

    7.10%

    Downside

    3.23%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.40
    $12.25
    downward going graph

    9.68%

    Downside

    690.32%

    Upside

    downward going graph

enGene Holdings Inc. Common Stock share price movements today

Previous Close
$1.44
Open
$1.44
Volume
2.2M
Day's Low - High
$1.44 - $1.60
52 Week Low - High
$1.40 - $12.25

enGene Holdings Inc. Common Stock Historical Returns

1 Month Return
-80.62 %
3 Month Return
-85.28 %
1 Year Return
-50 %
3 Year Return
0 %
5 Year Return
0 %

enGene Holdings Inc. Common Stock Stock Fundamentals & Key Indicators

Check enGene Holdings Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$99.8M

EPS (TTM)

-1.9161

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-127.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-46.07%

enGene Holdings Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of enGene Holdings Inc. Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$99.8MNANA0.00%
BUY$38.0B119.7%71.3912.55%
NA$32.7BNA71.448.94%
BUY$110.4B109.14%25.8435.51%
BUY$74.7B39.88%17.3929.65%

Stock Returns calculator for enGene Holdings Inc. Common Stock Stock including INR - Dollar returns

The enGene Holdings Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

enGene Holdings Inc. Common Stock investment value today

Current value as on today

₹60,402

Returns

-₹39,598

(-39.6%)

Returns from enGene Holdings Inc. Common Stock Stock

-₹46,181 (-46.18%)

Dollar Impact

₹6,583 (+6.58%)

Analyst Recommendation on enGene Holdings Inc. Common Stock Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for enGene Holdings Inc. Common Stock. Average target price of $5.6

enGene Holdings Inc. Common Stock Share Price Target

Get share price movements and forecasts by analysts on enGene Holdings Inc. Common Stock.

What analysts predicted

72.32%UPSIDE

Target Price

$5.6

Current Price

$1.55

Analyzed by

11 Analysts

Target

$5.60

enGene Holdings Inc. Common Stock target price $5.6, a slight upside of 72.32% compared to current price of $1.55. According to 11 analysts rating.

Indian Investors' Interest in enGene Holdings Inc. Common Stock Stock

Search interest for enGene Holdings Inc. Common Stock Stock has increased by 540% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:540% versus previous 30 day period

enGene Holdings Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Jan 2024
Mar 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Total Revenue
-
-
-
-
0
-
-
-
-
-
Gross Profit
0
-
0
0
0
0
0
0
0
0
Operating Income
-10
-
-17
-16
-17
-26
-27
-29
-39
-31
EBITDA
-10
-
-14
-13
-14
-23
-24
-27
-37
-28
Interest Expense
0
-
0
0
0
0
0
0
0
0
Depreciation
0
-
0
0
0
0
0
0
0
0
Income Before Tax
-10
-
-14
-14
-15
-24
-25
-28
-38
-29
Income Tax Expense
0
-
0
0
0
0
0
0
0
-
Net Income
-10
-14
-14
-14
-15
-24
-25
-28
-37
-29
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-3187.29%
0.00%
0.00%
0.00%
0.00%
0.00%

enGene Holdings Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

Oct 2020
Dec 2020
Oct 2021
Dec 2021
Oct 2022
Dec 2022
Oct 2023
Dec 2023
Oct 2024
Oct 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
0
-
0
0
Operating Income
-13
-
-15
-
-19
-
-26
-
-62
-123
EBITDA
-12
-
-18
-
-22
-
-94
-
-52
-113
Interest Expense
3
-
5
-
1
-
4
-
2
2
Depreciation
0
-
0
-
0
-
0
-
0
0
Income Before Tax
-15
-
-23
-
-24
-
-99
-
-55
-117
Income Tax Expense
4
-
4
-
0
-
0
-
0
-
Net Income
-15
-15
-23
-23
-24
-24
-99
-99
-55
-117
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

enGene Holdings Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

Jan 2024
Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Net Income
-10
-14
-14
-15
-24
-25
-28
-37
-29
Operating Cash Flow
-7
-14
-7
-19
-25
-22
-25
-24
-28
Investing Cash Flow
0
0
0
-125
-84
17
1
40
-126
Financing Cash Flow
12
193
0
60
0
0
0
1
141
Change in Cash
4
179
-7
-84
-110
-4
-24
17
-13

enGene Holdings Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

Oct 2021
Oct 2022
Oct 2023
Oct 2024
Oct 2025
Net Income
-23
-24
-99
-55
-117
Operating Cash Flow
-15
-17
-24
-48
-99
Investing Cash Flow
0
0
0
-125
-25
Financing Cash Flow
22
27
86
265
1
Change in Cash
6
9
61
91
-122

enGene Holdings Inc. Common Stock News & Key Events

  • img

    Today's Timeline - 11 November

    Tue, 09:07 PM

    -

    enGene reports promising Phase 2 trial data, leading to a 64.73% stock increase.

Insights on enGene Holdings Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 90.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ENGN stock has moved down by -83.7%

About enGene Holdings Inc. Common Stock

enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.
OrganisationenGene Holdings Inc. Common Stock
Headquarters4868 Rue Levy, Montreal, QC, Canada, H4R 2P1
IndustryBiotechnology
CEOMr. Ronald H. W. Cooper
E-voting on sharesClick here to vote

Key Management of enGene Holdings Inc. Common Stock

Name

Title

Mr. Lee G. Giguere

Chief Legal Officer & Corporate Secretary

Mr. Ronald H. W. Cooper

President, CEO & Director

Mr. David Ryan Daws

CFO & Head of Business Development

Dr. Hussein Sweiti M.D., M.Sc.

Chief Medical Officer and Head of Research & Development

Dr. Anthony T. Cheung Ph.D.

Co-Founder & Chief Scientific Officer

Dr. Alexander Nichols Ph.D.

Chief Strategy & Operations Officer

Ms. Joan Connolly

Chief Technology Officer

Ms. Tara Place M.B.A.

Senior VP of Human Resources

Mr. Matthew Boyd

Chief Regulatory Officer

Ms. Jill Buck

Chief Development Officer

FAQs

What is enGene Holdings Inc. Common Stock share price today?

enGene Holdings Inc. Common Stock share price today is $1.55 as on . enGene Holdings Inc. Common Stock share today touched a day high of $1.6 and a low of $1.44.

What is the 52 week high and 52 week low for enGene Holdings Inc. Common Stock share?

enGene Holdings Inc. Common Stock share touched a 52 week high of $12.25 on and a 52 week low of $1.4 on . enGene Holdings Inc. Common Stock stock price today i.e. is trending at $1.55,which is 87.35% down from its 52 week high and 10.71% up from its 52 week low.

What is enGene Holdings Inc. Common Stock's market capitalisation today?

enGene Holdings Inc. Common Stock market capitalisation is $0.00T as on .

How to invest in enGene Holdings Inc. Common Stock Stock (ENGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for enGene Holdings Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in enGene Holdings Inc. Common Stock Shares that will get you 0.9677 shares as per enGene Holdings Inc. Common Stock share price of $1.55 per share as on May 13, 2026 at 10:40 pm IST.

What is the minimum amount required to buy enGene Holdings Inc. Common Stock Stock (ENGN) from India?

Indian investors can start investing in enGene Holdings Inc. Common Stock (ENGN) shares with as little as ₹95.705 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in enGene Holdings Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on enGene Holdings Inc. Common Stock share’s latest price of $1.55 as on May 13, 2026 at 10:40 pm IST, you will get 6.4516 shares of enGene Holdings Inc. Common Stock. Learn more about fractional shares .